Home › Targets › CD19
CD19 (12 companies · 51 programs)
Companies with an active program directed at CD19.
- CNTY-308 — Systemic Lupus Erythematosus Preclinical
- CNTY-308 — Lupus Nephritis Preclinical
- CNTY-308 — Idiopathic Inflammatory Myopathy Preclinical
- CNTY-308 — Diffuse Cutaneous Systemic Sclerosis Preclinical
- CNTY-101 — Systemic Lupus Erythematosus Phase 1
- CNTY-101 — Lupus Nephritis Phase 1
- CNTY-101 — Idiopathic Inflammatory Myopathy Phase 1
- CNTY-101 — Diffuse Cutaneous Systemic Sclerosis Phase 1
- CNTY-308
- resecabtagene autoleucel — Systemic Lupus Erythematosus Phase 1
- resecabtagene autoleucel — Lupus Nephritis Phase 1
- resecabtagene autoleucel — Dermatomyositis Phase 1
- resecabtagene autoleucel — Immune-Mediated Necrotizing Myopathy Phase 1
- resecabtagene autoleucel — Systemic Sclerosis Phase 1
- resecabtagene autoleucel — Generalized Myasthenia Gravis Phase 1
- resecabtagene autoleucel — Pemphigus Vulgaris Phase 1
- resecabtagene autoleucel — Autoimmune Diseases Phase 1
- miv-cel — Stiff Person Syndrome NDA Submitted
- miv-cel — Generalized Myasthenia Gravis Phase 3
- miv-cel — Progressive Multiple Sclerosis Phase 1
- miv-cel — Rheumatoid Arthritis Phase 2
- miv-cel — Lupus Nephritis Phase 1
- KYV-102 Phase 1
- KYV-201 Preclinical
- AlloNK — Rheumatoid Arthritis Phase 1
- AlloNK — Sjögren's Disease Phase 2
- AlloNK — Systemic Sclerosis Phase 2
- AlloNK — Idiopathic Inflammatory Myopathies Phase 2
- AlloNK — Systemic Lupus Erythematosus Phase 1
- AlloNK — Lupus Nephritis Phase 1
- budoprutug — Primary Membranous Nephropathy Phase 2
- budoprutug — Immune Thrombocytopenia Phase 2
- budoprutug — Systemic Lupus Erythematosus Phase 1
- budoprutug — Systemic Lupus Erythematosus Phase 1
- budoprutug — Primary Membranous Nephropathy Phase 1
- cemacabtagene ansegedleucel — Large B-Cell Lymphoma Phase 2
- ALLO-329 — Systemic Lupus Erythematosus Phase 1
- ALLO-329 — Idiopathic Inflammatory Myopathies Phase 1
- ALLO-329 — Systemic Sclerosis Phase 1
- vispa-cel — Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Phase 1
- vispa-cel — Relapsed/Refractory Large B Cell Lymphoma Phase 1
- vispa-cel — Large B-Cell Lymphoma Phase 3
- CLN-978 — Systemic Lupus Erythematosus Phase 1
- CLN-978 — Rheumatoid Arthritis Phase 1
- CLN-978 — Sjögren's Disease Phase 1
- CD19 t-haNK — Non-Hodgkin Lymphoma Phase 1
- CD19 t-haNK — Waldenström Macroglobulinemia Phase 1
- SG293 Preclinical
- SG293 — Non-Hodgkin Lymphoma Preclinical
- INB-619 — Systemic Lupus Erythematosus Preclinical
